Additionally, a study conducted by Mehrabadi and Zahedi on inflammatory markers in MS patients found that vitamin D supplementation did not significantly affect levels of IL-10, IL-17, or IFN-γ [67]. This evidence concerns the gene IL17A and myeloid sarcoma.